ResearcherSimcere Pharmaceutical (China)Active in the last 2 years

Dongsheng Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-2732-1328; OpenAlex author ID A5100758683. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Circulating Tumor DNA as a Biomarker in Pancreatic Cancer: Clinical Applications and Challenges. Last author DOI 10.14309/ctg.0000000000000999 ↗
Comparative analysis of the mutational landscape and evolutionary patterns of pancreatic ductal adenocarcinoma metastases in the liver or peritoneum. Co-author DOI 10.1016/j.heliyon.2024.e35428 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Guoliang Yao · 2 shared papers, 2024–2026 · strength 0.50
- Paper Circulating Tumor DNA as a Biomarker in Pancreatic Cancer: Clinical Applications and Challenges. DOI 10.14309/ctg.0000000000000999 ↗
- Paper Comparative analysis of the mutational landscape and evolutionary patterns of pancreatic ductal adenocarcinoma metastas… DOI 10.1016/j.heliyon.2024.e35428 ↗
Yonggang Fan · 1 shared paper, 2024 · strength 0.20
- Paper Comparative analysis of the mutational landscape and evolutionary patterns of pancreatic ductal adenocarcinoma metastas… DOI 10.1016/j.heliyon.2024.e35428 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.